Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Genmab
Genmab
Pfizer
OncoNano Medicine, Inc.
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Baylor College of Medicine
Checkpoint Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Celldex Therapeutics
Icahn School of Medicine at Mount Sinai
Corvus Pharmaceuticals, Inc.
Eastern Cooperative Oncology Group
Seagen Inc.
Institut Bergonié
Celgene
Baylor College of Medicine
Amgen
sigma-tau i.f.r. S.p.A.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Stanford University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center